X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
life sciences (54) 54
index medicus (51) 51
humans (50) 50
cancer (44) 44
hematology (32) 32
oncology (28) 28
female (24) 24
male (24) 24
[ sdv.can ] life sciences [q-bio]/cancer (22) 22
chemistry (22) 22
human necessities (22) 22
hygiene (22) 22
investigating or analysing materials by determining theirchemical or physical properties (22) 22
measuring (22) 22
medical or veterinary science (22) 22
metallurgy (22) 22
organic chemistry (22) 22
peptides (22) 22
physics (22) 22
preparations for medical, dental, or toilet purposes (22) 22
testing (22) 22
middle aged (20) 20
[sdv.can]life sciences [q-bio]/cancer (19) 19
abridged index medicus (19) 19
aged (19) 19
lymphoma (18) 18
adult (17) 17
immunology (15) 15
immunotherapy (14) 14
animals (13) 13
lymphomas (13) 13
rituximab (12) 12
[sdv]life sciences [q-bio] (11) 11
chemotherapy (11) 11
prognosis (11) 11
aged, 80 and over (10) 10
antineoplastic combined chemotherapy protocols - therapeutic use (10) 10
follicular lymphoma (10) 10
hemic and lymphatic diseases (10) 10
human health and pathology (10) 10
treatment outcome (10) 10
therapy (9) 9
care and treatment (8) 8
non-hodgkins-lymphoma (8) 8
antibodies, monoclonal - therapeutic use (7) 7
immune system diseases (7) 7
response criteria (7) 7
specific therapeutic activity of chemical compounds ormedicinal preparations (7) 7
survival (7) 7
transplantation (7) 7
[ sdv.mhep.hem ] life sciences [q-bio]/human health and pathology/hematology (6) 6
[sdv.mhep.hem]life sciences [q-bio]/human health and pathology/hematology (6) 6
antibodies, monoclonal, humanized - administration & dosage (6) 6
antineoplastic agents (6) 6
b-cell lymphoma (6) 6
expression (6) 6
hodgkin lymphoma (6) 6
lymphoid neoplasia (6) 6
mesh : humans (6) 6
neoplasms - immunology (6) 6
prospective studies (6) 6
recurrence (6) 6
[ sdv ] life sciences [q-bio] (5) 5
antibodies (5) 5
antibodies, monoclonal, murine-derived - administration & dosage (5) 5
antineoplastic combined chemotherapy protocols - administration & dosage (5) 5
combined modality therapy (5) 5
cytotoxicity (5) 5
disease-free survival (5) 5
drug therapy (5) 5
efficacy (5) 5
lenalidomide (5) 5
lymphoma - therapy (5) 5
mice (5) 5
monoclonal antibodies (5) 5
neoplasm recurrence, local - drug therapy (5) 5
neoplasms (5) 5
neoplasms - therapy (5) 5
nk cells (5) 5
phase-ii (5) 5
regulatory t-cells (5) 5
t-lymphocytes - immunology (5) 5
trial (5) 5
tumors (5) 5
young adult (5) 5
antibody (4) 4
antibody-dependent cell cytotoxicity (4) 4
antimitotic agents (4) 4
antineoplastic agents - therapeutic use (4) 4
antineoplastic combined chemotherapy protocols - adverse effects (4) 4
bortezomib (4) 4
brentuximab vedotin (4) 4
c-receptor polymorphisms (4) 4
cancer-immunotherapy (4) 4
chemical and pharmacologic phenomena (4) 4
chronic lymphocytic-leukemia (4) 4
cyclophosphamide (4) 4
disease progression (4) 4
drug resistance, neoplasm (4) 4
fc-gamma-riiia (4) 4
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (165) 165
French (8) 8
German (3) 3
Spanish (3) 3
Chinese (1) 1
Korean (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JAMA Dermatology, ISSN 2168-6068, 01/2018, Volume 154, Issue 1, p. 113
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 03/2012, Volume 122, Issue 3, pp. 1066 - 1075
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2017, Volume 377, Issue 13, pp. 1250 - 1260
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 06/2014, Volume 124, Issue 6, pp. 2668 - 2682
Journal Article
Clinical case reports, ISSN 2050-0904, 06/2017, Volume 5, Issue 6, p. 757
Differentiating chronic myelogenous leukemia in primary blast crisis (CML-BC) from de novo -positive acute myeloid leukemia (AML) is a diagnostic challenge... 
Journal Article
Clinical Case Reports, 06/2017, Volume 5, Issue 6, pp. 757 - 760
Key Clinical Message Differentiating chronic myelogenous leukemia in primary blast crisis (CML‐BC) from de novo BCR‐ABL1‐positive acute myeloid leukemia (AML)... 
Leukemia
Journal Article
Clinical Case Reports, ISSN 2050-0904, 06/2017, Volume 5, Issue 6, pp. 757 - 760
Key Clinical Message Differentiating chronic myelogenous leukemia in primary blast crisis (CML‐BC) from de novo BCR‐ABL1‐positive acute myeloid leukemia (AML)... 
Basophiloblast | chronic myeloid leukemia | BCR‐ABL1‐positive acute myeloid leukemia
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 01/2013, Volume 31, Issue 1, pp. 104 - 110
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 7/2010, Volume 107, Issue 29, pp. 12747 - 12754
Human tumors contain populations of both cancerous and host immune cells whose malignant signaling interactions may define each patient's disease trajectory.... 
T lymphocytes | Phosphorylation | Health outcomes | B lymphocytes | B cell lymphoma | T cell lymphoma | Stem cells | Lymphoma | Tumors | Cancer | Follicular lymphoma | Signaling profile | B-cell receptor | Phospho-flow cytometry | SURVIVAL | ACTIVATION | follicular lymphoma | signaling profile | CYCLOPHOSPHAMIDE | MULTIDISCIPLINARY SCIENCES | PHASE-III | IMMUNOGLOBULIN | phospho-flow cytometry | KAPPA-B | CANCER STEM-CELLS | HUMAN FOLLICULAR LYMPHOMA | ANTIGEN-RECEPTOR | NON-HODGKINS-LYMPHOMA | Lymphoma, Follicular - therapy | Reproducibility of Results | Prognosis | Lymphoma, Follicular - pathology | Humans | Phosphoprotein Phosphatases - metabolism | Disease Progression | Lymphocyte Subsets - immunology | Receptors, Antigen, B-Cell - immunology | Signal Transduction - immunology | Extracellular Space - metabolism | Models, Immunological | Phenotype | B-Lymphocytes - immunology | CD40 Antigens - metabolism | Lymphocytes, Tumor-Infiltrating - pathology | Lymphoma, Follicular - immunology | Survival Analysis | Lymphoma, Follicular - enzymology | B-Lymphocytes - pathology | Enzyme Activation | Lymphocyte Subsets - pathology | Lymphocytes, Tumor-Infiltrating - immunology | Development and progression | B cells | Cytokines | Health aspects | CD40 antigen | Cell survival | Tumor-infiltrating lymphocytes | Tumor cells | Lymphocytes T | Cell interactions | Cytometry | Interleukin 7 | Chemotherapy | Lymphocytes B | Microenvironments | Biological Sciences
Journal Article
JAMA DERMATOLOGY, ISSN 2168-6068, 01/2018, Volume 154, Issue 1, pp. 113 - 113
The article by Rivera et al is the first report of a previously undescribed side effect of checkpoint inhibitors: hair repigmentation (HR). In this significant... 
REGULATORY T-CELLS | DERMATOLOGY | Hair | B7-H1 Antigen | Humans | Immunotherapy | Cell Death | Programmed Cell Death 1 Receptor | Lung Neoplasms | Life Sciences | Human health and pathology | Immunology | Dermatology | Cancer
Journal Article
Haematologica, ISSN 0390-6078, 07/2018, Volume 103, Issue 8, pp. 1256 - 1268
Evading immune eradication is a prerequisite for neoplastic progression and one of the hallmarks of cancer. Here, we review the different immune escape... 
CLASS-II EXPRESSION | B-CELL LYMPHOMA | NERVOUS-SYSTEM LYMPHOMAS | PROGRESSION-FREE SURVIVAL | REGULATORY T-CELLS | NON-HODGKINS-LYMPHOMA | TUMOR-ASSOCIATED MACROPHAGES | POOR PATIENT SURVIVAL | HEMATOLOGY | INDEPENDENT PROGNOSTIC-FACTOR | FAS LIGAND EXPRESSION | Review
Journal Article